About ADVAC Therapeutics
ADVAC Therapeutics is a private company based in Columus, Ohio, incorporated in 2022 in Delaware. It has reported $500,000 raised in one offering on Form D since March 2026. Its chief executive is Mark Gossett.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Mar 10, 2026 | $500,000of $5.0M target | 1 | $500K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ADVAC Therapeutics's Form D filed Mar 10, 2026.
MG